在患有或没有慢性阻塞性肺病的患者中,对社区获得的肺炎进行微生物分析:一项全面的分子诊断研究
Dagfinn Lunde Markussen1,2, Christoffer Lindemann3, Sondre Serigstad4,5
1Department of Clinical Science, Faculty of Medicine, Bergen Integrated Diagnostic Stewardship Cluster, University of Bergen, Bergen, 5020, Norway. dafi@ihelse.net.
Pneumonia (Nathan Qld.)
|August 5, 2025
概括
伪omonas aeruginosa在患有慢性阻塞性肺病 (COPD) 的患者中更常见,这些患者患有社区获得性肺炎 (CAP). 高风险的COPD患者可能会从针对P. aeruginosa的向抗生素覆盖中受益.
科学领域:
- 肺部医学 肺部医学
- 传染性疾病 传染性疾病
- 微生物学 微生物学
背景情况:
- 社区获得性肺炎 (CAP) 对健康构成重大负担,特别是在慢性阻塞性肺病 (COPD) 患者身上.
- 本研究调查了COPD患者和没有COPD患者之间微生物检测的差异.
研究的目的:
- 为了比较社区获得性肺炎 (CAP) 患者的微生物检测,有或没有慢性阻塞性肺病 (COPD).
- 在CAP患者中识别Pseudomonas aeruginosa检测的预测因子.
主要方法:
- 对412名住院肺炎患者进行前性研究,其中包括136名COPD患者.
- 使用传统培养和多重PCR面板 (FilmArray肺炎面板Plus) 分析下呼吸道样本.
- 采用多变量波桑和后勤回归模型来确定预测因素并估计检测概率.
主要成果:
- 整体病原体检测率在COPD和非COPD组之间是相似的.
- 伪菌在COPD患者中明显更为普遍 (12.5%与3.1%相比,p < 0.001).
- 晚期COPD (GOLD 3-4),糖尿病和之前的P. aeruginosa检测独立地与风险增加有关.
结论:
- 伪菌在高风险的COPD患者中不成比例地流行.
- 考虑经验性P. aeruginosa覆盖范围,选择高风险的COPD患者与CAP.
- 需要进一步的研究来评估针对性的P. aeruginosa覆盖范围,以改善抗生素管理和患者的治疗结果.
相关概念视频
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
Pneumonia III: Complications and Assessment
441
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
441
Pneumonia I: Introduction
330
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
330
Pneumonia II: Pathophysiology
559
The pathophysiology of pneumonia involves the following steps:
559
Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K
Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K


